tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nxera Pharma Secures $4.8 Million Milestone Payment from Centessa
PremiumCompany AnnouncementsNxera Pharma Secures $4.8 Million Milestone Payment from Centessa
3M ago
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
Premium
Company Announcements
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
4M ago
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
Premium
Company Announcements
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
4M ago
Nxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
PremiumCompany AnnouncementsNxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
6M ago
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
Premium
Company Announcements
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
7M ago
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
Premium
Company Announcements
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
7M ago
Nxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
PremiumCompany AnnouncementsNxera Pharma Achieves Major Milestones in 2024, Eyes Further Growth
8M ago
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SOLTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
Premium
Company Announcements
Nxera Pharma Begins Key Insomnia Drug Trial in South Korea
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100